
Dive Into Dollar Tr...


| Price and Volume | |
|---|---|
| Recent Price | 24.91 |
| 52 Week High | 50.51 |
| 52 Week Low | 11.02 |
| Avg. Daily Vol. (Mil) | 1.05 |
| Beta (3 year) | 0.84 |
| Share Related Items | |
| Mkt Cap (Mil) | 1,192.63 |
| Shares Out (Mil) | 47.83 |
| Float (Mil) | 39.88 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 17.00 |
| Current Ratio | 17.80 |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | 0.00 |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 54.38 |
| Price/Book | 4.12 |
| Price/Cash Flow | -17.70 |
| Per Share Data | |
| Earnings | -2.05 |
| Sales | 0.46 |
| Book Value | 6.05 |
| Cash Flow | -1.41 |
| Business Summary | |
|---|---|
| Infinity Pharmaceuticals, Inc discovers, develops, and delivers medicines for the treatment of cancer and related conditions. | |
| General Information | |
| 780 Memorial Drive
Cambridge, MA 02139 |
|
| www.infi.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 154 | |
| CEO: Ms. Adelene Q. Perkins | |
| Short Interest | |
| Current Month (Mil) | 2.35 |
| Previous Month (Mil) | 3.79 |
| Short Interest Ratio (Days) | 2.10 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -22.50 |
| Return on Investments | -24.00 |
| Profitability | |
| Gross Margin | n.a. |
| EBIT Margin | n.a. |
| Profit Margin | 0.00 |